French Associates Institute for Agriculture and Biotechnology of Drylands, Jacob Blaustein Institutes for Desert Research, Ben-Gurion University of the Negev, 84990, Midreshet Ben-Gurion, Israel,
Biogerontology. 2013 Dec;14(6):603-8. doi: 10.1007/s10522-013-9445-4. Epub 2013 Jul 13.
Stem cells have become a major topic, both publicly and scientifically, owing to their potential to cure diseases and repair damaged tissues. Particular attention has been given to the so-called "induced pluripotent stem cells" (iPSCs) in which somatic cells are induced by the expression of transcription factor encoding transgenes-a methodology first established by Takahashi and Yamanaka (Cell 126:663-676, 2006)-to acquire pluripotent state. This methodology has captured researchers' imagination as a potential procedure to obtain patient-specific therapies while also solving both the problem of transplant rejection and the ethical concerns often raised regarding the use of embryonic stem cells in regenerative medicine. The study of the biology of stem cells/iPSCs, in recent years, has uncovered some fundamental weaknesses that undermine their potential use in transplantation therapies.
干细胞由于其治疗疾病和修复受损组织的潜力,已成为一个重要的研究课题,无论是在公众领域还是科学界。特别受到关注的是所谓的“诱导多能干细胞”(iPSCs),通过表达转录因子编码的转基因,体细胞被诱导获得多能性状态——这一方法最早由 Takahashi 和 Yamanaka(Cell 126:663-676, 2006)建立。这种方法激发了研究人员的想象力,认为它是一种潜在的方法,可以获得患者特异性治疗,同时解决移植排斥的问题,以及在再生医学中使用胚胎干细胞经常引起的伦理问题。近年来,对干细胞/iPSCs 生物学的研究揭示了一些根本性的弱点,这些弱点破坏了它们在移植治疗中的潜在应用。